Cochlear | COH - Cost Of Sales

Stock Price
166.83
Daily Change
-5.60 -3.25%
Monthly
-16.06%
Yearly
-38.22%
Q1 Forecast
170.76

Cochlear reported AUD319.2M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Ansell USD 605.3M 351.2M Dec/2025
Avita Medical AUD 3.3M 166K Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Fisher Paykel Healthcare NZD 402.8M 15.2M Dec/2025
Healius AUD 218.7M 110.8M Jun/2025
Integral Diagnostics AUD 11.53M 146K Jun/2024
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Mesoblast USD -7.6M 27.47M Dec/2025
Monash IVF AUD 27.42M 17.08M Dec/2025
Nanosonics AUD 24.22M 1.11M Dec/2025
Polynovo AUD 4.77M 2.77M Jun/2024
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 536.28M 21.52M Dec/2025
Sigma Healthcare AUD 1.55B 165.16M Dec/2024
Somnomed AUD 16.9M 2.11M Jun/2023
Sonic Healthcare AUD 751.66M 801.13M Dec/2024
Telix Pharmaceuticals AUD 221.36M 20.78M Dec/2025